Nature's Way Women's Fortify Extra Strength
Lacticaseibacillus rhamnosus GG
Strain code: ATCC 53103
CFU: 50 Billion CFU
View product →Current high-quality evidence does not support probiotics as an effective treatment for low back pain. Some probiotics, such as Lactobacillus rhamnosus GG, showed only minimal and clinically insignificant pain reduction in chronic low back pain with Modic changes. Probiotics have more established benefits in musculoskeletal health related to bone density and osteoarthritis pain, but not specifically for low back pain.
A high-quality randomized controlled trial (PMID 31309333) investigated Lactobacillus rhamnosus GG in patients with chronic low back pain and Modic type 1 or mixed changes. The study found no statistically significant differences in disability or pain outcomes between probiotic and placebo groups over one year, with only a small, clinically negligible reduction in back pain. Other studies focus on probiotics' effects on bone health, osteoarthritis pain, and musculoskeletal function, showing some benefits in bone mineral density and osteoarthritis-related pain and inflammation (PMIDs 39064686, 39553313, 33653743, 41457232). However, these findings do not directly translate to low back pain relief. Evidence for probiotics in functional abdominal pain and irritable bowel syndrome is more robust but unrelated to low back pain. Overall, probiotics are not proven effective for low back pain relief based on the supplied studies.
Studied for: Chronic low back pain with Modic type 1 or mixed changes
Effect size was small and unlikely to be clinically meaningful; no safety concerns reported.
Studied for: Rib fracture pain, knee osteoarthritis
Evidence supports pain relief in musculoskeletal conditions other than low back pain; further research needed.
Probiotic treatments in the studies reviewed were generally safe and well tolerated, with no significant differences in adverse events compared to placebo.
Evidence specific to probiotics for low back pain is limited to one high-quality RCT with minimal effect. Other studies focus on related musculoskeletal conditions or different populations. The small effect size and lack of clinically meaningful improvement limit recommendations. More targeted research is needed to clarify any potential role of probiotics in low back pain management.
These products contain microorganisms identified in the research analysis above.
Lacticaseibacillus rhamnosus GG
Strain code: ATCC 53103
CFU: 50 Billion CFU
View product →
Lacticaseibacillus rhamnosus GG
Strain code: ATCC 53103
CFU: 15 billion CFU
View product →Probiotics.info is an educational and research platform. Its content does not constitute medical advice.
By continuing, you acknowledge our policies and agree to our Terms of Use.
Necessary cookies keep the website working. You can also allow optional cookies for analytics and referral tracking.
You can change your cookie preferences later.